Last update 01 Nov 2024

Menarini International Operations Luxembourg SA

Private Company|
1999|
Luxembourg, Luxembourg

Overview

Tags

Infectious Diseases
Skin and Musculoskeletal Diseases
Other Diseases
Small molecule drug
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases3
Endocrinology and Metabolic Disease2
Immune System Diseases2
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug6
Synthetic peptide1
Top 5 TargetCount
ACE(Angiotensin-converting enzyme)1
PBPs x β-lactamase1
Nav1.5(Sodium channel protein type V alpha subunit)1
PDE5A(Phosphodiesterase 5A)1
Peptidoglycan1

Related

8
Drugs associated with Menarini International Operations Luxembourg SA
Meropenem/Vaborbactam
Target
PBPs x β-lactamase
Mechanism
PBPs inhibitors [+1]
Active Org.
Rempex Pharmaceuticals, Inc.Rempex Pharmaceuticals, Inc. [+4]
Originator Org.
Melinta Therapeutics, Inc.Melinta Therapeutics, Inc.
Active Indication
Bacteremia [+8]
Inactive Indication
Acute pyelonephritis [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date29 Aug 2017
Bilastine
Target
H1 receptor
Mechanism
H1 receptor antagonists
Active Org.
Faes Farma SA [+4]
Originator Org.
Faes Farma SA
Active Indication
Chronic Urticaria [+6]
Inactive Indication
Allergic rhinoconjunctivitis [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CA
First Approval Date21 Apr 2016
Oritavancin Diphosphate
Target
Peptidoglycan
Mechanism
Peptidoglycan inhibitors [+1]
Active Org.
Menarini International Operations Luxembourg SA [+3]
Originator Org.
The Medicines Company (Spain) SL
Active Indication
Skin and skin structure infections [+2]
Inactive Indication
Abscess [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date06 Aug 2014
43
Clinical Trials associated with Menarini International Operations Luxembourg SA
NCT06104423 / RecruitingPhase 4
Open-label, Multicenter, multinAtionaL, inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients - ARTEMISIA Study
CTR20243815 / CompletedPhase 1
评价注射用美罗培南韦博巴坦在中国健康受试者中的药代动力学特征以及安全性、耐受性的I期临床研究
[Translation] A phase I clinical study to evaluate the pharmacokinetic characteristics, safety and tolerability of meropenem and virbobactam for injection in healthy Chinese subjects
CTR20231032 / CompletedPhase 3
一项随机、双盲双模拟、阳性药物对照、多中心临床试验评价注射用美罗培南韦博巴坦在中国复杂性尿路感染（包括肾盂肾炎）患者中的有效性和安全性的III期研究
[Translation] A phase III randomized, double-blind, double-dummy, active drug-controlled, multicenter clinical trial to evaluate the efficacy and safety of meropenem and virbobactam for injection in Chinese patients with complicated urinary tract infections (including pyelonephritis)
100 Clinical Results associated with Menarini International Operations Luxembourg SA
Login to view more data
0 Patents (Medical) associated with Menarini International Operations Luxembourg SA
Login to view more data
100 Deals associated with Menarini International Operations Luxembourg SA
Login to view more data
100 Translational Medicine associated with Menarini International Operations Luxembourg SA
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
7
1
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free